Table 2 Ranking of macrolide nonsusceptibility among IPD isolates in Germany from 1992 to 2008 related to the sampling source (n = 11,807)
Sampling source | I% | R% | I+R% | total (n) |
|---|---|---|---|---|
Pharynx | 0.0 | 75.0 | 75.0 | 4 |
Pericard | 0.0 | 50.0 | 50.0 | 8 |
Mastoid | 0.0 | 40.0 | 40.0 | 10 |
BAL | 0.6 | 18.7 | 19.4 | 154 |
Others/unknown | 0.0 | 18.3 | 18.3 | 131 |
CSF | 0.2 | 17.7 | 17.8 | 1824 |
Blood | 0.3 | 15.6 | 15.9 | 9352 |
Pleural fluid | 0.4 | 14.7 | 15.1 | 252 |
Eye | 0.0 | 11.1 | 11.1 | 9 |
Ascites | 0.0 | 8.7 | 8.7 | 23 |
Joint | 0.0 | 5.6 | 5.6 | 36 |
Ear | 0.0 | 0.0 | 0.0 | 4 |
Total | 0.3 | 16.0 | 16.3 | 11807 |